Though various trials clearly show that THC and CBD make improvements to MS indicators, the effect is little. There exists also no convincing evidence that cannabinoids can slow or reverse the disease’s development.The objective of the new regulation came into impact on January 1, 2024 to allow medical supply-only merchants to operate in cities a